Vaccine News and Research

Latest Vaccine News and Research

Report finds decline in overall number and rate of healthcare-associated infections in Pennsylvania

The overall number and rate of healthcare-associated infections obtained while receiving medical care decreased more than 3 percent, according to an annual report released today by the Pennsylvania Department of Health.

29 Nov 2012

CEL-SCI's Multikine cancer drug receives key Japanese patent

CEL-SCI Corporation today announced that the Japanese patent office has issued a key patent covering CEL-SCI's investigational cancer drug, Multikine (Leukocyte Interleukin, Injection).

29 Nov 2012

China's SFDA approves QIAGEN careHPV Test and instrument platform

QIAGEN N.V. today announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform.

From QIAGEN Manchester Limited 29 Nov 2012

Factors increasing risk for pertussis in children evaluated

Research shows that children with pertussis infection are significantly less likely to have had all five diphtheria, tetanus, and acellular pertussis vaccine doses than uninfected children.

28 Nov 2012

Social media can reduce and prevent infectious diseases from spreading

When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. A Kansas State University-led research team is looking at social media as a tool to reduce and prevent diseases from spreading. Researchers are studying whether a well-timed post from a public authority or trustworthy person could be as beneficial as flu shots, hand-washing or sneezing into an elbow.

28 Nov 2012

Diptheria-tetanus-pertussis vaccine: an interview with Dr. Rudi Eggers, World Health Organisation

The Diptheria-tetanus-pertussis vaccine is sometimes also called the “triple vaccine” and has been around for about 50 years, and it protects against diphtheria, tetanus, and pertussis. These are serious diseases caused by bacteria.

28 Nov 2012

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

28 Nov 2012

Microneedle-based measles vaccine can immunize against measles

Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC).

28 Nov 2012

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

Scientists at Columbia University and the National Center for Atmospheric Research have adapted techniques used in modern weather prediction to generate local forecasts of seasonal influenza outbreaks.

28 Nov 2012

Global Polio Eradication Initiative IMB report optimistic but warns of possible polio resurgence in 2013

Though there is "significant risk" of a resurgence of polio in 2013, a new report from the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative (GPEI) is optimistic about the eradication of the disease, noting that 99.9 percent of polio has been stopped worldwide, with 175 cases reported so far in 2012 compared with 350,000 reported in 1988, BBC News reports.

28 Nov 2012

Federal travel budget policy affecting global health

Writing in the Diplomatic Courier Blog, Jaclyn Schiff, communications director for the American Society of Tropical Medicine and Hygiene, examines how "an Obama administration effort to curb reckless spending on events" is "making it harder for American researchers to collaborate effectively with their counterparts in other countries."

27 Nov 2012

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

Liver disease is a very broad family of diseases. There are two main categories of liver disease:

27 Nov 2012

New system can predict timing and severity of seasonal influenza outbreaks

Scientists have developed a system to predict the timing and severity of seasonal influenza outbreaks that could one day help health officials and the general public better prepare for them. The system adapts techniques used in modern weather prediction to turn real-time, Web-based estimates of influenza infection into local forecasts of seasonal flu.

27 Nov 2012

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.

27 Nov 2012

Avermectin family of drugs shows promise against TB

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

26 Nov 2012

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

mRNA vaccines offer protection against influenza A virus infections in various animal models

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.

26 Nov 2012

Online flu survey launched in the UK

Does “man flu” exist? How effective is the flu vaccine? And do pets keep you healthy? These are just some of the questions scientists from the London School of Hygiene & Tropical Medicine want to explore as they launch a nationwide flu survey.

22 Nov 2012

Single dose of Medicago's vaccine could offer cross-protection against flu

Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.

22 Nov 2012

Dropping of cold chain requirement for meningitis vaccine will improve access, IRIN reports

IRIN examines how the WHO's recent declaration that the MenAfriVac meningitis A vaccine can be transported or stored for up to four days without refrigeration will affect immunization campaigns in Africa's meningitis belt, which runs from Senegal to Ethiopia.

22 Nov 2012

Vaccine News and Research

Latest Vaccine News and Research

Report finds decline in overall number and rate of healthcare-associated infections in Pennsylvania

CEL-SCI's Multikine cancer drug receives key Japanese patent

China's SFDA approves QIAGEN careHPV Test and instrument platform

Factors increasing risk for pertussis in children evaluated

Social media can reduce and prevent infectious diseases from spreading

Diptheria-tetanus-pertussis vaccine: an interview with Dr. Rudi Eggers, World Health Organisation

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Microneedle-based measles vaccine can immunize against measles

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

Global Polio Eradication Initiative IMB report optimistic but warns of possible polio resurgence in 2013

Federal travel budget policy affecting global health

Liver disease therapies: an interview with Eric Halioua, CEO of Promethera Biosciences

New system can predict timing and severity of seasonal influenza outbreaks

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

Avermectin family of drugs shows promise against TB

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

mRNA vaccines offer protection against influenza A virus infections in various animal models

Online flu survey launched in the UK

Single dose of Medicago's vaccine could offer cross-protection against flu

Dropping of cold chain requirement for meningitis vaccine will improve access, IRIN reports

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in